TrialAnnals of the rheumatic diseases2016

Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment.

Juergen Rech et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.